Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
9.954M
Cash
862.1K
Avg Qtr Burn
-6.032M
Short % of Float
4.70%
Insider Ownership
14.33%
Institutional Own.
4.65%
Qtr Updated
07/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Bria-IMT™ (SV-BR-1-GM) Details Cancer, Breast cancer | Phase 3 Data readout | |
Bria-OTS™ + tislelizumab Details Breast cancer, Cancer | Phase 1/2 Data readout | |
Bria-PROS+ Details Cancer, Prostate cancer | IND Submission |